Braidwell LP Immatics N.V. Transaction History
Braidwell LP
- $1.63 Billion
- Q2 2025
Shares
4 transactions
Others Institutions Holding IMTX
# of Institutions
70Shares Held
94.8MCall Options Held
158KPut Options Held
0-
T. Rowe Price Investment Management, Inc. Baltimore, MD18.3MShares$118 Million0.06% of portfolio
-
Suvretta Capital Management, LLC New York, NY12MShares$77.2 Million2.23% of portfolio
-
Baker Bros. Advisors LP New York, NY10.2MShares$65.3 Million0.55% of portfolio
-
Perceptive Advisors LLC New York, NY9.38MShares$60.2 Million2.22% of portfolio
-
Rtw Investments, LP New York, NY6.97MShares$44.7 Million0.58% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $489M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...